Kimia Biosciences Limited

BSE:530313 Stock Report

Market Cap: ₹2.2b

Kimia Biosciences Balance Sheet Health

Financial Health criteria checks 3/6

Kimia Biosciences has a total shareholder equity of ₹3.3M and total debt of ₹495.1M, which brings its debt-to-equity ratio to 14959%. Its total assets and total liabilities are ₹999.7M and ₹996.4M respectively. Kimia Biosciences's EBIT is ₹15.0M making its interest coverage ratio 0.3. It has cash and short-term investments of ₹5.3M.

Key information

14,959.0%

Debt to equity ratio

₹495.14m

Debt

Interest coverage ratio0.3x
Cash₹5.34m
Equity₹3.31m
Total liabilities₹996.36m
Total assets₹999.67m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 530313's short term assets (₹614.1M) do not cover its short term liabilities (₹694.4M).

Long Term Liabilities: 530313's short term assets (₹614.1M) exceed its long term liabilities (₹302.0M).

Debt to Equity History and Analysis

Debt Level: 530313's net debt to equity ratio (14797.5%) is considered high.

Reducing Debt: 530313's debt to equity ratio has increased from 483.5% to 14959% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 530313 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 530313 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 40.4% per year.

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y